Inject by IV bolus over no less than 15 seconds. The constituent 8 -paradol is the most potent inhibitor of COX-1 and exhibits the greatest anti-platelet activity versus other gingerol analogues. Coadministration of indomethacin with marijuana has been shown to significantly decrease euphoria, tachycardia, and the intraocular pressure lowering activity of marijuana. In those with severe bleeding events, patients were often taking drugs that cause thrombocytopenia or affect platelet function or coagulation.
|Date Added:||21 March 2008|
|File Size:||61.72 Mb|
|Operating Systems:||Windows NT/2000/XP/2003/2003/7/8/10 MacOS 10/X|
|Price:||Free* [*Free Regsitration Required]|
Daypro is a registered trademark of G.
Concurrent use of NSAIDs may increase the risk of GI bleeding in patients with methotrexate-induced myelosuppression or mask fever, pain, swelling and perscribing signs and symptoms of an infection. In another study, ketorolac tromethamine dosed IV or IM was given with two doses of U of heparin to 11 healthy volunteers, resulting in a mean template bleeding time of 6.
Intravenous or Intramuscular dosage multiple-dose treatment. In comparison to other NSAIDs, ketorolac has been associated an increased incidence of GI effects and has dosing restrictions to limit these effects.
Antiepileptic Drugs Sporadic cases of seizures have been reported during concomitant use of TORADOL ketorolac tromethamine and antiepileptic drugs phenytoincarbamazepine. A decline in glomerular filtration or tubular secretion may impair the excretion ketorooac digoxin. The drug was well tolerated; efficacy was not assessed in the study. In patients with rheumatoid arthritis, methotrexate has been given concurrently with NSAIDs without apparent problems.
Contraindicated Moderate moderately elevated serum creatinine: In the kidney, prostaglandins, produced by both COX-1 and COX-2, are important regulators of sodium and water reabsorption through PGE2 and of renal function and hemodynamics via PGI2 in response to vasoconstrictive factors e. If these drugs must be coadministered, carefully monitor the estimated creatinine clearance, serum phosphorus, urine glucose, and urine protein prior to, and periodically during, treatment.
Major Due to the thrombocytopenic effects of chlorambucil, an additive risk of bleeding may be seen prescrkbing patients receiving concomitant anticoagulants, NSAIDs, platelet inhibitors, including aspirin, ASA, strontium chloride, and thrombolytic agents. Abrupt discontinuation of corticosteroids may lead to disease exacerbation. Major Educate patients about the signs of increased bleeding and the need to report these signs to a healthcare provider immediately if coadministration of dabigatran and a nonsteroidal antiinflammatory drug NSAID is necessary.
However, clinical documentation of interactions is lacking. The use of aspirin prescribint patients with aspirin-sensitive asthma has been associated with severe bronchospasm which can be fatal. Contraindicated with advanced renal impairment and in patients at risk for renal failure due to volume depletion GI: Though patients receiving intravenously administered bisphosphonates have a decreased incidence of GI adverse effects as compared to those taking orally administered bisphosphonates, nephrotoxicity is possible, and GI events are rarely reported.
Moderate It is possible that additive nephrotoxicity informaton occur in patients who receive nonsteroidal anti-inflammatory drugs NSAIDs concurrently with other nephrotoxic agents, such as streptomycin. Moderate Although the thrombocytopenic effects of cisplatin are limited, an additive risk of bleeding may be seen in patients receiving concomitant therapy with non-steroidal antiinflammatory agents NSAIDs. infkrmation
Toradol (Ketorolac Tromethamine): Side Effects, Interactions, Warning, Dosage & Uses
The volume of distribution and clearance of ketorolac in pediatric patients was higher than those observed in adult subjects see Table 1. Nonsteroidal antiinflammatory drugs NSAIDs may increase the risk for nephrotoxicity when used concurrently.
J Ocul Pharmacol Ther. Major Due to the thrombocytopenic effects of pentostatin, an additive risk of bleeding may be seen in patients receiving concomitant anticoagulants, NSAIDs, platelet inhibitors, including aspirin, strontium chloride, and thrombolytic agents. Prescgibing have been reports that ocular-applied NSAIDs may cause increased bleeding of ocular tissues including hyphemas in conjunction with ocular procedures.
Patients need to remove contact lenses before administering ketorolac ophthalmic solution. J Cataract Refract Surg. Contraindicated during labor and delivery because it may adversely affect fetal circulation and inhibit uterine contractions; contraindicated in breastfeeding women because of potential adverse effects of prostaglandin-inhibiting drugs on neonates Renal: Ulcerative stomatitis and exacerbations of inflammatory bowel disease have been noted during post-marketing surveillance with ketorolac or other NSAIDs.
Toradol ketorolac tromethamine can cause serious gastrointestinal GI adverse events including bleeding, pprescribing and perforation, of the stomach, small intestine, or iformation intestinewhich can be fatal. Contraindicated with previous or currently active peptic ulcer disease, previous or current GI bleeding or perforation.
Major Because ibuprofen lysine exerts similar pharmacologic characteristics to other systemic NSAIDs, including COX-2 inhibitors, additive pharmacodynamic effects, including a potential increase for additive adverse GI effects, may be seen if prescribiny lysine is used with other NSAIDs. IM, 10 min; PO, min Duration: Demonstrated hypersensitivity to ketorolac or allergic manifestations to aspirin or other NSAIDs; appropriate counteractive measures must be available when first ketorolac injection is given.